Quantcast
Home > Quotes > PACB
PACB

Pacific Biosciences of California, Inc. Common Stock (PACB) Quote & Summary Data

$7.61
*  
0.01
0.13%
Get PACB Alerts
*Delayed - data as of Nov. 15, 2018  -  Find a broker to begin trading PACB now
Exchange:NASDAQ
Industry: Capital Goods
Community Rating:
View:    PACB Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
8
Today's High / Low
$ 7.675 / $ 7.56
Share Volume
2,989,101
50 Day Avg. Daily Volume
4,341,291
Previous Close
$ 7.62
52 Week High / Low
$ 7.84 / $ 2.02
Market Cap
1,133,143,398
P/E Ratio
NE
Forward P/E (1y)
NE
Earnings Per Share (EPS)
$ -0.74
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.53

Intraday Chart

Shares Traded

Share Volume:
2,989,101
50 Day Avg. Daily Volume:
4,341,291

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.74

Trading Range

The current last sale of $7.61 is 276.73% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 7.675 $ 7.84
 Low: $ 7.56 $ 2.02

Company Description (as filed with the SEC)

We design, develop and manufacture sequencing systems to help scientists resolve genetically complex problems. Based on our novel Single Molecule, Real-Time (SMRT®) sequencing technology, our products enable: de novo genome assembly to finish genomes in order to more fully identify, annotate and decipher genomic structures; full-length transcript analysis to improve annotations in reference genomes, characterize alternatively spliced isoforms in important gene families, and find novel genes; targeted sequencing to more comprehensively characterize genetic variations; and real-time kinetic information for epigenome characterization. Our technology provides high accuracy, ultra-long reads, uniform coverage and the ability to simultaneously detect epigenetic changes. PacBio® sequencing systems, including consumables and software, provide a simple, fast, end-to-end workflow for SMRT sequencing.  ... More ...  


Risk Grade

Where does PACB fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 7.61
Open Date:
Nov. 15, 2018
Close Price:
$ 7.61
Close Date:
Nov. 15, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x